Difference between revisions of "Other CNS embryonal tumours"

From Libre Pathology
Jump to navigation Jump to search
(molecular)
m (vauthors --> authors)
 
(6 intermediate revisions by one other user not shown)
Line 37: Line 37:
Currently it is a exlcusion criteria encompassing four morphological subgroups
Currently it is a exlcusion criteria encompassing four morphological subgroups
*CNS neuroblastomas  
*CNS neuroblastomas  
**often infants.
**Tumors can be huge.
*CNS ganglioneuroblastomas.
*CNS ganglioneuroblastomas.
** often characterized by FOXR2 fusions: ''CNS neuroblastoma with FOXR2 activation (NB‐FOXR2)''
** often characterized by FOXR2 fusions: ''CNS neuroblastoma with FOXR2 activation (NB‐FOXR2)''
Line 46: Line 48:
** BCOR-positive IHC: ''HGNET BCOR‐altered neuroepithelial tumours''
** BCOR-positive IHC: ''HGNET BCOR‐altered neuroepithelial tumours''


Currently four distinct subtypes can be discriminated by molecular analysis: NB-FOXR2, HGNET-MN1, EFT-CIC and HGNET-BCOR.<ref>{{cite journal |vauthors=Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, Johann PD, Sahm F, Reimand J, Mackay A, Carvalho DM, Remke M, Phillips JJ, Perry A, Cowdrey C, Drissi R, Fouladi M, Giangaspero F, Łastowska M, Grajkowska W, Scheurlen W, Pietsch T, Hagel C, Gojo J, Lötsch D, Berger W, Slavc I, Haberler C, Jouvet A, Holm S, Hofer S, Prinz M, Keohane C, Fried I, Mawrin C, Scheie D, Mobley BC, Schniederjan MJ, Santi M, Buccoliero AM, Dahiya S, Kramm CM, von Bueren AO, von Hoff K, Rutkowski S, Herold-Mende C, Frühwald MC, Milde T, Hasselblatt M, Wesseling P, Rößler J, Schüller U, Ebinger M, Schittenhelm J, Frank S, Grobholz R, Vajtai I, Hans V, Schneppenheim R, Zitterbart K, Collins VP, Aronica E, Varlet P, Puget S, Dufour C, Grill J, Figarella-Branger D, Wolter M, Schuhmann MU, Shalaby T, Grotzer M, van Meter T, Monoranu CM, Felsberg J, Reifenberger G, Snuderl M, Forrester LA, Koster J, Versteeg R, Volckmann R, van Sluis P, Wolf S, Mikkelsen T, Gajjar A, Aldape K, Moore AS, Taylor MD, Jones C, Jabado N, Karajannis MA, Eils R, Schlesner M, Lichter P, von Deimling A, Pfister SM, Ellison DW, Korshunov A, Kool M |title=New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs |journal=Cell |volume=164 |issue=5 |pages=1060–1072 |date=February 2016 |pmid=26919435 |pmc=5139621 |doi=10.1016/j.cell.2016.01.015 |url=}}</ref>
Currently four distinct subtypes can be discriminated by molecular analysis: NB-FOXR2, HGNET-MN1, EFT-CIC and HGNET-BCOR.<ref>{{cite journal |authors=Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, Johann PD, Sahm F, Reimand J, Mackay A, Carvalho DM, Remke M, Phillips JJ, Perry A, Cowdrey C, Drissi R, Fouladi M, Giangaspero F, Łastowska M, Grajkowska W, Scheurlen W, Pietsch T, Hagel C, Gojo J, Lötsch D, Berger W, Slavc I, Haberler C, Jouvet A, Holm S, Hofer S, Prinz M, Keohane C, Fried I, Mawrin C, Scheie D, Mobley BC, Schniederjan MJ, Santi M, Buccoliero AM, Dahiya S, Kramm CM, von Bueren AO, von Hoff K, Rutkowski S, Herold-Mende C, Frühwald MC, Milde T, Hasselblatt M, Wesseling P, Rößler J, Schüller U, Ebinger M, Schittenhelm J, Frank S, Grobholz R, Vajtai I, Hans V, Schneppenheim R, Zitterbart K, Collins VP, Aronica E, Varlet P, Puget S, Dufour C, Grill J, Figarella-Branger D, Wolter M, Schuhmann MU, Shalaby T, Grotzer M, van Meter T, Monoranu CM, Felsberg J, Reifenberger G, Snuderl M, Forrester LA, Koster J, Versteeg R, Volckmann R, van Sluis P, Wolf S, Mikkelsen T, Gajjar A, Aldape K, Moore AS, Taylor MD, Jones C, Jabado N, Karajannis MA, Eils R, Schlesner M, Lichter P, von Deimling A, Pfister SM, Ellison DW, Korshunov A, Kool M |title=New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs |journal=Cell |volume=164 |issue=5 |pages=1060–1072 |date=February 2016 |pmid=26919435 |pmc=5139621 |doi=10.1016/j.cell.2016.01.015 |url=}}</ref>
 
==Histology==
CNS neuroblastoma:
*Groups of neurocytic cells.
*Variable neuropil-rich stroma.
*Small round blue cells.
 
HGNET-BCOR:
*Circumscribed growth.
*Perivascular pesudorosettes.
*Fibrillary areas resembling glioma.
*Palisading necrosis.
*Absence of microvascular proliferation.


==IHC==
==IHC==
Line 61: Line 76:
* CK may be focally +ve.
* CK may be focally +ve.


HGNET-BCOR <ref>{{cite journal |vauthors=Ferris SP, Velazquez Vega J, Aboian M, Lee JC, Van Ziffle J, Onodera C, Grenert JP, Saunders T, Chen YY, Banerjee A, Kline CN, Gupta N, Raffel C, Samuel D, Ruiz-Diaz I, Magaki S, Wilson D, Neltner J, Al-Hajri Z, Phillips JJ, Pekmezci M, Bollen AW, Tihan T, Schniederjan M, Cha S, Perry A, Solomon DA |title=High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis |journal=Brain Pathol. |volume=30 |issue=1 |pages=46–62 |date=January 2020 |pmid=31104347 |doi=10.1111/bpa.12747 |url=}}</ref>
HGNET-BCOR <ref>{{cite journal |authors=Ferris SP, Velazquez Vega J, Aboian M, Lee JC, Van Ziffle J, Onodera C, Grenert JP, Saunders T, Chen YY, Banerjee A, Kline CN, Gupta N, Raffel C, Samuel D, Ruiz-Diaz I, Magaki S, Wilson D, Neltner J, Al-Hajri Z, Phillips JJ, Pekmezci M, Bollen AW, Tihan T, Schniederjan M, Cha S, Perry A, Solomon DA |title=High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis |journal=Brain Pathol. |volume=30 |issue=1 |pages=46–62 |date=January 2020 |pmid=31104347 |doi=10.1111/bpa.12747 |url=}}</ref>
* OLIG +ve.
* OLIG variable +ve.
* BCOR +ve.
* BCOR +ve.
* Syn -ve.
* Syn -ve.
Line 69: Line 84:
* NEUN +/-ve.
* NEUN +/-ve.


DDx:
==DDx:==
* [[AT/RT]]
* [[AT/RT]]
* [[ETMR]]
* [[ETMR]]
* [[Anaplastic ependymoma]]
* [[Anaplastic ependymoma]]
* H3F3A G34-mutated [[Glioblastoma]]
* H3F3A G34-mutated [[Glioblastoma]]
* Metastasis of [[Ewing sarcoma]]


[[Category:Neuropathology]]
[[Category:Neuropathology]]
[[Category:Neuropathology tumours]]

Latest revision as of 20:27, 24 May 2020

Other CNS embryonal tumours
Diagnosis in short

Other CNS embryonal tumorH&E stain.
Synonyms CNS-PNET
LM DDx small round blue cell tumours
IHC S-100 +ve, Syn +/-ve
Site brain, spinal cord
Prevalence rare - typically in children and young adults
Prognosis poor (WHO Grade IV)


Other CNS embryonal tumor, was introduced in the WHO 2016 classification of CNS tumors. Some of these tumors of this category has been previously designated as CNS-PNET but this terminology has been abandoned.

General

Other CNS embryonal tumours are a group of primitive neuroeptithelial tumors that are to be classified in distinct molecular groups in the future. Currently it is a exlcusion criteria encompassing four morphological subgroups

  • CNS neuroblastomas
    • often infants.
    • Tumors can be huge.
  • CNS ganglioneuroblastomas.
    • often characterized by FOXR2 fusions: CNS neuroblastoma with FOXR2 activation (NB‐FOXR2)
  • CNS medulloepithelioma.
    • but absence of C19MC alteration, otherwise classified as ETMR
  • CNS embryonal tumour, NOS
    • Similarities to astroblastoma: High‐grade neuroepithelial tumours with MN1 alteration (HGNET‐MN1)
    • NUTM1-positive IHC: Ewing's sarcoma family tumour with CIC alteration (EFT‐CIC)
    • BCOR-positive IHC: HGNET BCOR‐altered neuroepithelial tumours

Currently four distinct subtypes can be discriminated by molecular analysis: NB-FOXR2, HGNET-MN1, EFT-CIC and HGNET-BCOR.[1]

Histology

CNS neuroblastoma:

  • Groups of neurocytic cells.
  • Variable neuropil-rich stroma.
  • Small round blue cells.

HGNET-BCOR:

  • Circumscribed growth.
  • Perivascular pesudorosettes.
  • Fibrillary areas resembling glioma.
  • Palisading necrosis.
  • Absence of microvascular proliferation.

IHC

CNS Ganglioneuroblastoma + Neuroblastoma

  • Syn -/+ve.
  • Vim -ve.
  • GFAP usu -ve.
  • MIB-1 usu high.

Medulloepthelioma

  • Syn +/-ve.
  • NF +/-ve.
  • GFAP usu -ve.
  • CK may be focally +ve.

HGNET-BCOR [2]

  • OLIG variable +ve.
  • BCOR +ve.
  • Syn -ve.
  • GFAP -ve.
  • EMA: dots +ve.
  • NEUN +/-ve.

DDx:

  1. ↑ Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, Johann PD, Sahm F, Reimand J, Mackay A, Carvalho DM, Remke M, Phillips JJ, Perry A, Cowdrey C, Drissi R, Fouladi M, Giangaspero F, Łastowska M, Grajkowska W, Scheurlen W, Pietsch T, Hagel C, Gojo J, Lötsch D, Berger W, Slavc I, Haberler C, Jouvet A, Holm S, Hofer S, Prinz M, Keohane C, Fried I, Mawrin C, Scheie D, Mobley BC, Schniederjan MJ, Santi M, Buccoliero AM, Dahiya S, Kramm CM, von Bueren AO, von Hoff K, Rutkowski S, Herold-Mende C, Frühwald MC, Milde T, Hasselblatt M, Wesseling P, Rößler J, Schüller U, Ebinger M, Schittenhelm J, Frank S, Grobholz R, Vajtai I, Hans V, Schneppenheim R, Zitterbart K, Collins VP, Aronica E, Varlet P, Puget S, Dufour C, Grill J, Figarella-Branger D, Wolter M, Schuhmann MU, Shalaby T, Grotzer M, van Meter T, Monoranu CM, Felsberg J, Reifenberger G, Snuderl M, Forrester LA, Koster J, Versteeg R, Volckmann R, van Sluis P, Wolf S, Mikkelsen T, Gajjar A, Aldape K, Moore AS, Taylor MD, Jones C, Jabado N, Karajannis MA, Eils R, Schlesner M, Lichter P, von Deimling A, Pfister SM, Ellison DW, Korshunov A, Kool M (February 2016). "New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs". Cell 164 (5): 1060–1072. doi:10.1016/j.cell.2016.01.015. PMC 5139621. PMID 26919435. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139621/.
  2. ↑ Ferris SP, Velazquez Vega J, Aboian M, Lee JC, Van Ziffle J, Onodera C, Grenert JP, Saunders T, Chen YY, Banerjee A, Kline CN, Gupta N, Raffel C, Samuel D, Ruiz-Diaz I, Magaki S, Wilson D, Neltner J, Al-Hajri Z, Phillips JJ, Pekmezci M, Bollen AW, Tihan T, Schniederjan M, Cha S, Perry A, Solomon DA (January 2020). "High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis". Brain Pathol. 30 (1): 46–62. doi:10.1111/bpa.12747. PMID 31104347.
Retrieved from "https://librepathology.org/w/index.php?title=Other_CNS_embryonal_tumours&oldid=50795"